VOYA Investment Management
MLYS icon

VOYA Investment Management’s Mineralys Therapeutics MLYS Stock Holding History

VOYA Investment Management’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.4M Sell
125,991
-90,098
-42% -$2.47M ﹤0.01% 1022
2026
Q1 		$5.85M Buy
216,089
+103,417
+92% +$3.03M 0.01% 778
2025
Q4 		$4.09M Sell
112,672
-25,854
-19% -$1.04M ﹤0.01% 945
2025
Q3 		$5.25M Buy
138,526
+88,050
+174% +$1.9M 0.01% 855
2025
Q2 		$683K Buy
50,476
+34,418
+214% +$499K ﹤0.01% 1744
2025
Q1 		$255K Buy
+16,058
New +$185K ﹤0.01% 2202

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VOYA Investment Management's MLYS Position: Q2 2026 in Review

VOYA Investment Management reduced its Mineralys Therapeutics (MLYS) stake by 42% in Q2 2026, selling an estimated $2.47M and leaving 125,991 shares worth $3.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1022.

VOYA Investment Management first reported a position in MLYS in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.85M in Q1 2026. 224 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • VOYA Investment Management held 125,991 shares of Mineralys Therapeutics worth $3.4M as of Q2 2026.
  • VOYA Investment Management sold 90,098 Mineralys Therapeutics shares in Q2 2026, an estimated $2.47M.
  • Mineralys Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1022 holding.
  • VOYA Investment Management first reported a position in Mineralys Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • VOYA Investment Management's Mineralys Therapeutics position peaked at $5.85M in Q1 2026.
  • 224 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.